Montasir

Experienced Health Economist with expertise in Economic Evaluation, Modelling in Economics Evaluation, Statistics, Econometrics, and Health Technology Assessment. Skilled in evaluating the cost analysis, efficacy, and health effects of drugs across various disease areas. Proficient in using advanced statistical tools and methodologies to generate evidence-based insights for healthcare decision-making.

Skilled in Real-World Evidence Generation, Cost-Effectiveness and Budget Impact Analyses, and Survival Analysis. I am proficient in STATA, R, Python, and Excel VBA. I also bring expertise in Systematic Review, Meta-Analysis, Research Design, and Project Management to deliver impactful health economic insights.

I am a Health Economist at the Health Economics and Policy Research Unit (HEPRU), Centre for Evaluation and Methods, part of the Wolfson Institute of Population Health (WIPH). I started working at the Queen Mary University of London (QMUL) in July 2022. My primary tasks are Economic Evaluation, cost-effectiveness analysis, and implementing Bedside Electronic Transfusion Checks at Barts Health NHS Trust hospitals.

Before joining QMUL, I worked at the University of Oslo, Norwegian Institute of Public Health, Oslo Metropolitan University, and NordicRWE. Throughout my career, I have provided my expertise in Economic Evaluation to various organizations. I hold an MPhil in Health Economics, Policy, and Management, specializing in Economic Evaluation in Healthcare, from the University of Oslo, Norway. I also have an MPhil in Economics from the University of Oslo, Norway, and an MSc in Economics from Jahangirnagar University, Bangladesh.